A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
2019 · Leukemia · 221 citations
https://doi.org/10.1038/s41375-019-0539-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
720
Citations
9
h-index
9
i10-index
Andrew Belch is an academic researcher. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Multiple Myeloma Research and Treatments & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 9, co-authored 12 publications.
Click to start Chat